Bright Pink helps to save women’s lives from breast and ovarian cancer by empowering them to know their risk and manage their health proactively. Through digital innovation, engaging content, and strategic partnerships, we meet women in their daily lives with the actionable and accessible information and resources they need to understand and reduce their risk.
In the U.S., breast cancer prevention focuses almost exclusively on mammography for women over 40. At Bright Pink, we seek to improve upon this one-size-fits-all standard of care by empowering women and their providers to be proactive about breast and ovarian health at a young age based on personal risk factors. This approach improves access to early detection and preventive care making interventions less costly and more likely to increase equitable health outcomes for all women.
In the 12 years since our founding, Bright Pink has helped to shift the national conversation around breast and ovarian cancer from one focused on awareness, illness, and treatment to one focused on action, health promotion, and prevention. Highlights of our work include:
- Launching the only comprehensive, patient-facing digital breast and ovarian cancer risk assessment tool, AssessYourRisk.org (AYR), and enabling more than 1.5 million women to assess their personal risk;
- Identifying more than 600,000 women at elevated risk and directing them to appropriate resources;
- Engaging 30,000 women in breast and ovarian self-awareness through regular mobile health reminders;
- Training nearly 20,000 women’s health providers to stratify and manage breast and ovarian cancer risk in young women;
- Connecting over 3,000 women at high risk to peer support;
- Accepting the 2016 Webby Award for the best user interface for AssessYourRisk.org;
- Winning the 2018 Blue Cross and Blue Shield of Illinois Health Equity Innovation Challenge and the opportunity to pilot AYR with Medicaid members; and;
- Receiving initial study findings, in April 2019, from researchers at Northwestern University Feinberg School of Medicine indicating that AssessYourRisk.org is a valid tool for identifying women at increased risk of breast and ovarian cancer when compared against National Comprehensive Cancer Network guidelines.